The Prescrire journal has published its assessment of drugs to avoid in 2025, highlighting 106 drugs with an unfavourable benefit-risk balance. Among them, 88 are currently marketed in France ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback